Cyrille Yao

ORCID: 0000-0003-0197-2533
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Child Nutrition and Water Access
  • Child Nutrition and Feeding Issues
  • Poverty, Education, and Child Welfare
  • Food Security and Health in Diverse Populations
  • Corneal surgery and disorders
  • Leaf Properties and Growth Measurement
  • Ophthalmology and Visual Impairment Studies

Programme PAC-CI
2020-2024

University Hospital Medical Center at Treichville
2023

National Taiwan University
2000

Global access to acute malnutrition treatment is low. Different programmes using different nutritional products manage cases of severe and moderate separately. We aimed assess whether integrating into one programme, a single product reducing the dose as child improves, could achieve similar or higher individual efficacy, increase coverage, minimise costs compared with current programmes.We conducted an open-label, non-inferiority, randomised controlled trial in Democratic Republic Congo....

10.1016/s2214-109x(22)00041-9 article EN cc-by-nc-nd The Lancet Global Health 2022-03-15

Current standard management of severe acute malnutrition uses ready-to-use therapeutic food (RUTF) at a single weight-based calculation resulting in an increasing amount RUTF provided to the family as child's weight increases during recovery. Using gradually reduced dosage child recovers could reduce costs while achieving similar growth response.We conducted open-label, non-inferiority, randomised controlled trial Democratic Republic Congo. Children aged 6-59 months with mid-upper-arm...

10.1016/j.eclinm.2023.101878 article EN cc-by-nc-nd EClinicalMedicine 2023-02-28

Globally, access to treatment for severe and moderate acute malnutrition is very low, in part because different protocols products are used separate programs. New approaches, defining (AM) as mid-upper arm circumference (MUAC) < 125 mm or oedema, being investigated compare effectiveness current Optimizing Malnutrition (OptiMA) one such strategy that treats AM with product - ready-to-use therapeutic food, RUTF at reduced dosage the child improves.This study aimed determine whether OptiMA...

10.3389/fpubh.2023.1199036 article EN cc-by Frontiers in Public Health 2023-07-05

Introduction Acute malnutrition (AM) is a continuum condition, arbitrarily divided into moderate and severe AM (SAM) categories, funded managed in separate programmes under different protocols. Optimising acute MAlnutrition (OptiMA) treatment aims to simplify optimise management by treating children with mid-upper arm circumference (MUAC) &lt;125 mm or oedema one product—ready-to-use therapeutic food—at gradually tapered dose. Our main objective was compare the OptiMA strategy standard...

10.1136/bmjopen-2020-041213 article EN cc-by BMJ Open 2020-12-01

Abstract Acute malnutrition (AM) causes large loss of life and disability in children Africa. Researchers are testing innovative approaches to increase the efficiency treatment programs This paper presents results a cost-effectiveness analysis one such program Democratic Republic Congo (DRC) based on secondary randomized controlled trial Optimizing Treatment for Malnutrition (OptiMA), conducted DRC 2018–20. A total 896 aged 6–59 months with mid-upper arm circumference (MUAC) &amp;lt;125 mm...

10.1093/heapol/czae106 article EN cc-by-nc-nd Health Policy and Planning 2024-11-08

Background: Current standard management of severe acute malnutrition uses ready-to-use therapeutic food (RUTF) at an increasing dosage as the child’s weight increases during recovery. Using RUTF a gradually reduced child recovers could optimise costs while achieving similar growth response.Methods: We conducted open-label, non-inferiority, randomised controlled trial in Democratic Republic Congo. Children aged 6-59 months with mid-upper arm circumference (MUAC) less than 115 mm or...

10.2139/ssrn.4099994 article EN SSRN Electronic Journal 2022-01-01

The main objective was to compare the OptiMA strategy- ie.supplementing with ready-to-use therapeutic food at a gradually reduced doses- current national standard protocol. This non-inferiority, individually randomised controlled clinical trial conducted in Democratic Republic of Congo. Children 6–59 months MUAC < 125 mm or weight-for-height Zscore< −3 oedema and without medical complication were randomized either arm followed for 6 months. outcome binary composite indicator 6-months post...

10.1093/cdn/nzab035_019 article EN cc-by-nc-nd Current Developments in Nutrition 2021-06-01

The main secondary objective of OptiMA-DRC trial was to compare the OptiMA strategy, ie.supplementing with one product, ready-to-use therapeutic food at a gradually reduced doses, current national nutritionnal standard protocol in children uncomplicated severe acute malnutrition (SAM) inclusion (MUAC < 115 mm or WHZ< −3 oedema) both arms. This non-inferiority, individually randomised controlled clinical conducted Kasai province, Democratic Republic Congo (DRC) between July 2019 and 2020....

10.1093/cdn/nzab035_018 article EN cc-by-nc-nd Current Developments in Nutrition 2021-06-01
Coming Soon ...